# Phosphomannomutase 2-congenital disorder of glycosylation: exploring the role of N-glycosylation on the endocrine axes

## TL;DR

This paper explores how a genetic disorder affecting protein glycosylation impacts the endocrine system, leading to various hormonal issues.

## Contribution

The paper provides new insights into how N-glycosylation affects endocrine function in PMM2-CDG, improving clinical understanding and management.

## Key findings

- Endocrinopathies, including hypergonadotrophic hypogonadism, are common in PMM2-CDG.
- Hypoglycosylation disrupts hormonal function across multiple endocrine axes.
- Adrenal insufficiency is a rare but underdiagnosed endocrine abnormality in PMM2-CDG.

## Abstract

Congenital disorders of glycosylation (CDG) are a heterogeneous group of inborn errors of metabolism caused by impaired protein glycosylation. Among these, PMM2-CDG, caused by defective phosphomannomutase 2 activity and affecting protein N-glycosylation, is the most prevalent. As glycoproteins are involved in almost every physiological process, the clinical manifestations in PMM2-CDG are diverse and multisystemic. In the endocrine system, glycoproteins are present in every axis, acting as hormones, prohormones, receptors, enzymes, and transport proteins. Hypoglycosylation can alter hormonal function on multiple levels. As a result, endocrinopathies are frequently part of the clinical spectrum of PMM2-CDG, particularly hypergonadotrophic hypogonadism and pubertal abnormalities in female patients. Symptoms of endocrine involvement, especially hyperinsulinemic hypoglycemia and failure to thrive during infancy, can be the presenting sign of the disease. The clinical spectrum of PMM2-CDG endocrinopathy is variable; for example, thyroid involvement can range from isolated transitory hyperthyrotropinemia to clinical hypothyroidism. Some endocrine abnormalities, such as adrenal insufficiency, are uncommon and probably underdiagnosed in PMM2-CDG. The new insights into the role of N-glycosylation on the endocrine system over the past twenty years have deepened our understanding of this complex disorder and should enable us to improve and personalize the clinical management of these patients.